The tweet was deleted by the author.
But we saved everything 🙂.
Zymeworks has disclosed its financial results for the third quarter of 2025, along with a corporate update.
The pharmaceutical company, known for its focus on innovative therapeutics, shared that its financial performance aligns with its strategic objectives. For detailed figures and further insights into their financial positioning, readers are directed to Zymeworks' latest press release. As the industry continues to evolve, investors and stakeholders closely watch Zymeworks' developments.